MCID: LYM048
MIFTS: 29

Lymphoma, Large-Cell, Immunoblastic

Categories: Immune diseases, Rare diseases

Aliases & Classifications for Lymphoma, Large-Cell, Immunoblastic

MalaCards integrated aliases for Lymphoma, Large-Cell, Immunoblastic:

Name: Lymphoma, Large-Cell, Immunoblastic 52 37
Large Cell Immunoblastic Lymphoma 52
Lymphoma Large Cell Immunoblastic 54
Immunoblastic Large-Cell Lymphoma 71

Classifications:



External Ids:

UMLS 71 C0079746

Summaries for Lymphoma, Large-Cell, Immunoblastic

MalaCards based summary : Lymphoma, Large-Cell, Immunoblastic, also known as large cell immunoblastic lymphoma, is related to lymphoma and reticulosarcoma. An important gene associated with Lymphoma, Large-Cell, Immunoblastic is MYC (MYC Proto-Oncogene, BHLH Transcription Factor), and among its related pathways/superpathways are Immune response IL-23 signaling pathway and Immune response IFN alpha/beta signaling pathway. The drugs Cefepime and Orange have been mentioned in the context of this disorder. Affiliated tissues include b cells, bone and bone marrow.

Related Diseases for Lymphoma, Large-Cell, Immunoblastic

Diseases related to Lymphoma, Large-Cell, Immunoblastic via text searches within MalaCards or GeneCards Suite gene sharing:

(show all 13)
# Related Disease Score Top Affiliating Genes
1 lymphoma 10.4
2 reticulosarcoma 10.2
3 immune deficiency disease 10.0
4 anaplastic large cell lymphoma 10.0
5 richter's syndrome 10.0
6 acquired immunodeficiency syndrome 10.0
7 lung giant cell carcinoma 9.6 TIMP1 MYC
8 gingival fibromatosis 9.6 TIMP1 MYC
9 fibrosarcoma 9.5 TIMP1 MYC
10 adenocarcinoma 9.5 TIMP1 MYC
11 pancreatic adenocarcinoma 9.5 TIMP1 MYC
12 gastric adenocarcinoma 9.4 TIMP1 MYC
13 squamous cell carcinoma, head and neck 9.2 TIMP1 MYC

Graphical network of the top 20 diseases related to Lymphoma, Large-Cell, Immunoblastic:



Diseases related to Lymphoma, Large-Cell, Immunoblastic

Symptoms & Phenotypes for Lymphoma, Large-Cell, Immunoblastic

Drugs & Therapeutics for Lymphoma, Large-Cell, Immunoblastic

Drugs for Lymphoma, Large-Cell, Immunoblastic (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 357)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Cefepime Approved, Investigational Phase 3 88040-23-7 5479537
2 Orange Approved Phase 3
3
Ketamine Approved, Vet_approved Phase 3 6740-88-1 3821
4
Cyclophosphamide Approved, Investigational Phase 2, Phase 3 50-18-0, 6055-19-2 2907
5
Iron Approved, Experimental Phase 3 15438-31-0, 7439-89-6 27284 23925
6
Vincristine Approved, Investigational Phase 3 57-22-7, 2068-78-2 5978
7
Fludarabine Approved Phase 2, Phase 3 21679-14-1, 75607-67-9 30751
8
Guaifenesin Approved, Investigational, Vet_approved Phase 3 93-14-1 3516
9
Melphalan Approved Phase 2, Phase 3 148-82-3 460612 4053
10
Busulfan Approved, Investigational Phase 2, Phase 3 55-98-1 2478
11
Thiotepa Approved, Investigational Phase 2, Phase 3 52-24-4 5453
12
Iodine Approved, Investigational Phase 3 7553-56-2 807
13
Doxorubicin Approved, Investigational Phase 3 23214-92-8 31703
14
Prednisone Approved, Vet_approved Phase 3 53-03-2 5865
15
Hydrocortisone Approved, Vet_approved Phase 3 50-23-7 5754
16
Hydrocortisone acetate Approved, Vet_approved Phase 3 50-03-3
17
Cisplatin Approved Phase 3 15663-27-1 2767 441203 84093
18
Idarubicin Approved Phase 3 58957-92-9 42890
19
Bleomycin Approved, Investigational Phase 3 11056-06-7 5360373
20
Levoleucovorin Approved, Investigational Phase 3 68538-85-2
21
Acyclovir Approved Phase 3 59277-89-3 2022
22
Dalteparin Approved Phase 3 9005-49-6
23
Tinzaparin Approved Phase 3 9041-08-1, 9005-49-6 25244225
24
Levofloxacin Approved, Investigational Phase 3 100986-85-4 149096
25
Ofloxacin Approved Phase 3 82419-36-1 4583
26
Darbepoetin alfa Approved, Investigational Phase 3 11096-26-7, 209810-58-2
27
Fentanyl Approved, Illicit, Investigational, Vet_approved Phase 3 437-38-7 3345
28
Tazobactam Approved Phase 3 89786-04-9 123630
29
Vancomycin Approved Phase 3 1404-90-6 14969 441141
30
Piperacillin Approved Phase 3 66258-76-2 43672
31
Caspofungin Approved Phase 3 162808-62-0, 179463-17-3 2826718 468682
32
Itraconazole Approved, Investigational Phase 3 84625-61-6 55283
33
Captopril Approved Phase 3 62571-86-2 44093
34
Fluconazole Approved, Investigational Phase 3 86386-73-4 3365
35
Ribavirin Approved Phase 3 36791-04-5 37542
36
Palivizumab Approved, Investigational Phase 3 188039-54-5
37
Morphine Approved, Investigational Phase 3 57-27-2 5288826
38
Mercaptopurine Approved Phase 3 50-44-2 667490
39
Amphotericin B Approved, Investigational Phase 3 1397-89-3 5280965 14956
40
Cobalt Approved, Experimental Phase 3 7440-48-4 104729
41
Dextromethorphan Approved Phase 3 125-71-3 5360696 5362449
42
Estradiol Approved, Investigational, Vet_approved Phase 3 50-28-2 5757
43
Norgestimate Approved, Investigational Phase 3 35189-28-7 6540478
44
Moxifloxacin Approved, Investigational Phase 3 354812-41-2, 151096-09-2 152946
45
Ethinyl Estradiol Approved Phase 3 57-63-6 5991
46
Polyestradiol phosphate Approved Phase 3 28014-46-2
47
St. John's Wort Approved, Investigational, Nutraceutical Phase 3 84082-80-4
48
Ginseng Approved, Investigational, Nutraceutical Phase 3 50647-08-0
49
Glutamic acid Approved, Nutraceutical Phase 3 56-86-0 33032
50 Pancreatic Polypeptide Investigational Phase 3 59763-91-6

Interventional clinical trials:

(show top 50) (show all 542)
# Name Status NCT ID Phase Drugs
1 Evaluation of Allogeneic Marrow Transplants Depleted of T-Cells by CD34+ Selection in Patients Undergoing Transplantation With an Unrelated Matched or 1 Antigen Mismatched Donor or a 1 Antigen Mismatched Related Donor Completed NCT00003398 Phase 4 cyclophosphamide;thiotepa
2 A Randomised Study of High Dose Chemotherapy/Radiotherapy and Autologous Bone Marrow Transplantation in Patients With High Grade Malignant Non-Hodgkin's Lymphoma (Kiel Classification) According to Prognostic Groups Unknown status NCT00003815 Phase 3 carmustine;cyclophosphamide;cytarabine;doxorubicin hydrochloride;etoposide;melphalan;prednisolone;vincristine sulfate
3 The Utility of LymphoScan Imaging in the Dectection of Residual Tumor After Chemotherapy and/or Radiotherapy in Patients With Non-Hodgkin's Lymphoma Unknown status NCT00003338 Phase 2, Phase 3
4 The Utility of LymphoScan Imaging in the Localization and Staging of Patients With Non-Hodgkin's Lymphoma Unknown status NCT00003337 Phase 3
5 A Randomized Phase III Study to Assess Intensification of the Conditioning Regimen for Allogenic Stem Cell Transplantation (ALLO-SCT) for Leukemia or Myelodysplastic Syndrome With a High Risk of Relapse Unknown status NCT00002989 Phase 3 busulfan;cyclophosphamide;idarubicin;melphalan
6 Randomised Trial Comparing Chemotherapy Mit CHOEP (Cyclophosphamid, Doxorubicin, Vincristin, Etoposid Und Prednison) In 21-Day Intervals In Standard And Escalated Doses In Patients Aged 18-60 Years Of Age With Aggresive Non-Hodgkin-Lymphomas Favourable Prognoses Unknown status NCT00053768 Phase 3 EPOCH regimen;cyclophosphamide;doxorubicin hydrochloride;etoposide;prednisone;vincristine sulfate
7 A Prospective Randomised Phase III Trial of Early Hospital Discharge Versus Standard Inpatient Management of Cancer Patients With Low-Risk Febrile Neutropenia Receiving Oral Antibiotics. Oral Antibiotics for Neutropenic Sepsis Giving Early Hospital Discharge [ORANGE] Unknown status NCT00445497 Phase 3 amoxicillin-clavulanate potassium;ciprofloxacin
8 Multicenter, Double-Blind, Randomized Study to Compare the Safety and Efficacy of Levofloxacin With That of Cefepime in the Treatment of Fever and Neutropenia - Phase IIIB Unknown status NCT00020865 Phase 3 cefepime hydrochloride;levofloxacin
9 A Randomized Trial to Evaluate Early High Dose Therapy and Autologous Bone Marrow Transplantation as Part of Planned Initial Therapy for Poor Risk Intermediate/High Grade NHL Unknown status NCT00003578 Phase 3 CHOP regimen;carmustine;cyclophosphamide;cytarabine;doxorubicin hydrochloride;etoposide;melphalan;prednisone;vincristine sulfate
10 A Randomized Double-Blind Controlled Trial of Ketamine Versus Placebo in Conjunction With Best Pain Management in Neuropathic Pain in Cancer Patients Unknown status NCT01316744 Phase 3 ketamine hydrochloride
11 A European Randomized Multicenter Study of Interferon Alfa-2b Versus No Treatment After Intensive Therapy and Autologous Hematopoietic Stem Cell Transplantation for Relapsing Lymphoma Patients (Non-Hodgkin Lymphomas and Hodgkin's Disease) Unknown status NCT00003924 Phase 3
12 Total Body Irradiation, Etoposide, Cyclophosphamide and Autologous Peripheral Blood Stem Cell Transplantation Followed by Randomization to Therapy With Interleukin-2 Versus Observation for Patients With Non-Hodgkin's Lymphoma Completed NCT00002649 Phase 3 cyclophosphamide;etoposide
13 INSPIRE: An Internet-based RCT for Long-term Survivors of Hematopoietic Stem Cell Transplantation Completed NCT00799461 Phase 3
14 Phase III Rituxan/BEAM vs. Bexxar/BEAM With Autologous Hematopoietic Stem Cell Transplantation (ASCT) for Persistent or Relapsed Chemotherapy Sensitive Diffuse Large B-cell Non-Hodgkin's Lymphoma (BMT CTN #0401) Completed NCT00329030 Phase 3 Autologous transplantation using rituxan/BEAM;Autologous transplantation using Bexxar/BEAM
15 A RANDOMIZED PROSPECTIVE TRIAL OF CHOP VERSUS MCOP IN ELDERLY PATIENTS WITH INTERMEDIATE AND HIGH GRADE NON-HODGKIN'S LYMPHOMA (AGED 65 YEARS AND OVER) Completed NCT00002576 Phase 3 cyclophosphamide;doxorubicin hydrochloride;mitoxantrone hydrochloride;prednisolone;vincristine sulfate
16 RANDOMIZED COMPARISON OF ALTERNATING TRIPLE THERAPY ("ATT") VERUS CHOP IN PATIENTS WITH INTERMEDIATE GRADE LYMPHOMAS AND IMMUNOBLASTIC LYMPHOMAS WITH INTERNATIONAL INDEX 2-5 Completed NCT00002565 Phase 3 CHOP regimen;cisplatin;cyclophosphamide;cytarabine;doxorubicin hydrochloride;etoposide;idarubicin;ifosfamide;mesna;methylprednisolone;mitoxantrone hydrochloride;prednisone;vincristine sulfate
17 Phase III Trial Comparing CHOP ot PMitCEBO in Good Risk Patients With Histologically Aggresive Non Hodgkin's Lymphoma Completed NCT00005867 Phase 3 CHOP regimen;cyclophosphamide;doxorubicin hydrochloride;etoposide;mitoxantrone hydrochloride;prednisolone;vincristine sulfate
18 Phase III Trial of CHOP Versus CHOP and Chimeric Anti-CD20 Monoclonal Antibody (IDEC-C2B8) in Older Patients With Diffuse Mixed, Diffuse Large Cell and Immunoblastic Large Cell Histology Non-Hodgkin's Lymphoma Completed NCT00003150 Phase 3 CHOP regimen;cyclophosphamide;doxorubicin hydrochloride;prednisone;vincristine sulfate
19 A Phase III Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effects of Fragmin (5,000 IU Subcutaneously) in Preventing Catheter-Related Complications When Given Daily to Cancer Patients With Central Venous Catheters Completed NCT00006083 Phase 3 Fragmin
20 A Randomized, Prospective Double-Blind, Placebo-Controlled Trial of Prophylactic Oral Levofloxacin Following Chemotherapy for Lymphoma and Solid Tumors Completed NCT00005590 Phase 3 levofloxacin
21 A Randomized, Open-Label, Multicenter Study Of Darbepoetin Alfa Administered Once Every Two Weeks (Q2W) Compared With rHuEPO Administered Once Every Week (QW) For The Treatment Of Anemia In Subjects With Non-Myeloid Malignancies Receiving Multiple Chemotherapy Completed NCT00070382 Phase 3 darbepoetin alfa;epoetin alfa
22 Does Hypericum Reduce Fatigue in Cancer Patients on Chemotherapy? A Randomized, Double-Blind, Placebo-Controlled Clinical Trial Completed NCT00005805 Phase 3
23 Vancomycin Versus Placebo in Persistently Febrile Granulocytopenic Patients Given Piperacillin/Tazobactam Completed NCT00003805 Phase 3 piperacillin sodium;piperacillin-tazobactam;tazobactam sodium;vancomycin
24 The Effects of Procrit (Epoetin Alfa) on Hemoglobin Symptom Distress and Quality of Life During Chemotherapy in Lymphoma Patients With Mild to Moderate Anemia A Multicenter Trial Completed NCT00003341 Phase 3
25 Standard Chemotherapy (CHOP Regimen) Versus Sequential High-Dose Chemotherapy With Autologous Stem Cell Transplantation in Patients With Newly Diagnosed Aggressive Non-Hodgkin's Lymphomas and Poor Prognostic Factors: A Randomized Phase III Study (MISTRAL) Completed NCT00003215 Phase 3 CHOP regimen;cyclophosphamide;cytarabine;doxorubicin hydrochloride;etoposide;leucovorin calcium;melphalan;methotrexate;methylprednisolone;mitoxantrone hydrochloride;prednisone;therapeutic hydrocortisone;vincristine sulfate
26 A Randomized Prospective Study of Early Intensification Versus Alternating Triple Therapy for Patients With Poor Prognosis Lymphoma Completed NCT00002835 Phase 3 Carmustine;Cisplatin (CDDP);Cyclophosphamide;Cytarabine (ARA-C);Etoposide (VP-16);Idarubicin;Ifosfamide;Leucovorin Calcium;Melphalan;Methotrexate;Methylprednisolone;mitoxantrone hydrochloride (DHAD);Vincristine Sulfate
27 Randomized Study Comparing 4 and 6 Cycles of Chemotherapy With CHOP (Cyclophosphamide, Doxorubicin, Vincristine and Prednisone) at 21-day Intervals, Both With 6 Cycles of Immunotherapy With the Monoclonal Anti-CD20-Positive B-Cell Lymphoma Aged 18-60 Years Having no Risk Factor (Age-Adjusted IPI=0) and No Large Tumor Mass (Diameter <7,5cm) [FLYER 6-6-6-4 Study] Completed NCT00278421 Phase 3 cyclophosphamide;doxorubicin hydrochloride;prednisone;vincristine sulfate
28 A Double-Blind Study Of Nutritional Intervention For The Treatment Of Cancer Cachexia Using Juven® Nutritional Supplement Completed NCT00053053 Phase 3
29 A Phase III, Randomized Study of the Effects of Parenteral Iron, Oral Iron, or No Iron Supplementation on the Erythropoietic Response to Darbepoetin Alfa for Cancer Patients With Chemotherapy-Associated Anemia Completed NCT00661999 Phase 3 sodium ferric gluconate complex in sucrose
30 Preparatory Aid to Improve Decision Making About Cancer Clinical Trials (PRE-ACT) Completed NCT00750009 Phase 3
31 Phase III Study of Captopril in Patients Undergoing Autologous Bone Marrow/Stem Cell Transplantation Completed NCT00004230 Phase 3 captopril;cyclophosphamide
32 SWOG-9704 A Randomized Phase III Trial Comparing Early High Dose Chemoradiotherapy and an Autologous Stem Cell Transplant to Conventional Dose CHOP Chemotherapy Plus Rituximab for CD20+ B Cell Lymphomas (With Possible Late Autologous Stem Cell Transplant) for Patients With Diffuse Aggressive Non-Hodgkin's Lymphoma in the High-Intermediate and High Risk International Classification Prognostic Groups Completed NCT00004031 Phase 3 CHOP regimen;carmustine;cyclophosphamide;doxorubicin hydrochloride;etoposide;prednisone;vincristine sulfate
33 A Randomized, Comparative Study of Itraconazole Versus Fluconazole for Prevention of Aspergillus Infections in Peripheral Blood Stem Cell and Marrow Transplant Recipients Completed NCT00003883 Phase 3 fluconazole;itraconazole
34 A Randomized Double-Blind Placebo-Controlled Phase III Study To Evaluate The Safety And Efficacy Of Palivizumab Combined With Aerosolized Ribavirin Compared To Ribavirin Alone To Treat RSV Pneumonia In Patients With Bone Marrow Transplants (BMT) Completed NCT00014391 Phase 3 ribavirin
35 A Phase III Multicenter Study of Cytomegalovirus Prophylaxis With Valacyclovir for the Prevention of Serious Fungal and Bacterial Infections Among Cytomegalovirus Seronegative Recipients of Cytomegalovirus Seropositive Sx Stem Cell Transplants Completed NCT00045292 Phase 3 acyclovir;acyclovir sodium;valacyclovir
36 Music Video and Adolescent/Young Adult Resilience During Transplant Completed NCT00305851 Phase 3
37 Randomized Study Comparing an Immuno-Chemotherapy With 6 Cycles of the Monoclonal Anti-CD20 Antibody Rituximab in Combination With 6 Cycles of Chemotherapy With CHOP ( Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone) at 21-day Intervals or 14-day Intervals, Both With or Without Consolidating Radiotherapy or Large Tumour Masses (≥7.5 cm) and/or Extranodal Involvement in Patients With Aggressive CD20 B-Cell Lymphoma Aged 18 to 60 Years With Age-Adjusted IPI=1 (All) or IPI=0 With a Large Tumour Mass (≥7.5 cm) [UNFOLDER 21/14 Study] Completed NCT00278408 Phase 3 cyclophosphamide;doxorubicin hydrochloride;prednisone;vincristine sulfate
38 A Strategic Study to Determine the Optimal Moment to Initiate Systemic Antifungal Therapy With Ambisome in Granulocytopenic Cancer Patients With Unexplained Fever Refractory to Empirical Antibacterials Completed NCT00003938 Phase 3 liposomal amphotericin B
39 A Multicenter, Double-Blind, Randomized, Comparative Study To Evaluate The Safety, Tolerability, And Efficacy Of MK-0991 Versus (Amphotericin B) Liposome For Injection As Empirical Therapy In Patients With Persistent Fever And Neutropenia Completed NCT00008359 Phase 3 caspofungin acetate;liposomal amphotericin B
40 The Use of American Ginseng (Panax Quinquefolius) to Improve Cancer-Related Fatigue: A Randomized, Double-Blind, Placebo-Controlled Phase III Study Completed NCT00719563 Phase 3 American ginseng
41 Phase III Randomized Trial of an Opioid Titration Order Sheet Compared to Standard of Care in Patients With Cancer Related Pain. Completed NCT00666211 Phase 3
42 A Phase III Study of Large Cell Lymphomas in Children and Adolescents: Comparison of APO vs APO + IDMTX/HDARA-C and Continuous vs Bolus Infusion of Doxorubicin Completed NCT00002618 Phase 3 cytarabine;doxorubicin hydrochloride;leucovorin calcium;mercaptopurine;methotrexate;prednisone;vincristine sulfate
43 Randomized Placebo Controlled Double Blind Study of Restasis Versus Placebo in Primary Prevention of Ocular GVHD After Allogeneic Stem Cell Transplantation Completed NCT00755040 Phase 3 cyclosporine ophthalmic emulsion
44 A Randomized Multicentre Study Comparing G-CSF Mobilized Peripheral Blood and G-CSF Stimulated Bone Marrow in Patients Undergoing Matched Sibling Transplantation for Hematologic Malignancies Completed NCT00438958 Phase 3
45 A Phase III Double-Blind Equivalence Study of Two Different Formulations of Slow-Release Morphine Followed by a Randomization Between Dextromethorphan or Placebo Plus Statex SR for Chronic Cancer Pain Relief in Terminally Ill Patients Completed NCT00003687 Phase 3 dextromethorphan hydrobromide;morphine sulfate
46 Phase III Trial of T Lymphocyte Depletion by Elutriation and CD34 Add-Back for Allogeneic Bone Marrow Transplantation Completed NCT00265837 Phase 3
47 Randomized Trial of Autologous GVHD for Refractory Lymphoma Completed NCT00003414 Phase 3 busulfan;cyclophosphamide;cyclosporine
48 Phase III, Randomized, Double-Blind, Placebo-Controlled Crossover Trial of Ondansetron in the Control of Chronic Nausea and Vomiting Not Due to Antineoplastic Therapy in Patients With Advanced Cancer Completed NCT00006348 Phase 3 ondansetron
49 Glutamic Acid to Decrease Vincristine Toxicity in Children With Cancer Completed NCT00369564 Phase 3 glutamic acid
50 Randomized Trial of CHOP Chemotherapy With or Without Rituximab (Chimeric Anti-CD20 Antibody) for HIV-Associated Non-Hodgkin's Lymphoma Completed NCT00003595 Phase 3 CHOP regimen;cyclophosphamide;doxorubicin hydrochloride;prednisone;vincristine sulfate

Search NIH Clinical Center for Lymphoma, Large-Cell, Immunoblastic

Cell-based therapeutics:


LifeMap Discovery
Data from LifeMap, the Embryonic Development and Stem Cells Database
Read about Lymphoma, Large-Cell, Immunoblastic cell therapies at LifeMap Discovery.

Genetic Tests for Lymphoma, Large-Cell, Immunoblastic

Anatomical Context for Lymphoma, Large-Cell, Immunoblastic

MalaCards organs/tissues related to Lymphoma, Large-Cell, Immunoblastic:

40
B Cells, Bone, Bone Marrow, T Cells, Liver, Myeloid, Breast

Publications for Lymphoma, Large-Cell, Immunoblastic

Articles related to Lymphoma, Large-Cell, Immunoblastic:

# Title Authors PMID Year
1
Primary effusion lymphoma: a distinct clinicopathologic entity associated with the Kaposi's sarcoma-associated herpes virus. 54
8695812 1996
2
Biologic aspects of human immunodeficiency virus-related lymphoma. 61
1457505 1992
3
Relationship between the clinical aggressiveness of large cell immunoblastic lymphomas and expression of 92 kDa gelatinase (type IV collagenase) and tissue inhibitor of metalloproteinases-1 (TIMP-1) RNAs. 54
1421616 1992
4
Definition of two distinct types of AIDS-associated non-Hodgkin lymphoma. 61
2265114 1990
5
Nodular paragranuloma can transform into high-grade malignant lymphoma of B type. 61
2591946 1989
6
[Metastatic malignant lymphoma of the skull with extradural and extracranial extension. Case report]. 61
2479873 1989
7
Primary adrenal lymphoma. 61
2644013 1989
8
Malignant lymphoma, large cell immunoblastic clear cell showing unusual histologic picture. 61
2956826 1987
9
Bone marrow manifestations of peripheral T-cell lymphoma. A study of 30 cases. 61
3490173 1986
10
Case report 269. Diagnosis: malignant lymphoma (large cell, immunoblastic type) with widespread dissemination in the skeleton as well as lymph nodes and probably the liver and spleen. 61
6547004 1984

Variations for Lymphoma, Large-Cell, Immunoblastic

Expression for Lymphoma, Large-Cell, Immunoblastic

Search GEO for disease gene expression data for Lymphoma, Large-Cell, Immunoblastic.

Pathways for Lymphoma, Large-Cell, Immunoblastic

Pathways related to Lymphoma, Large-Cell, Immunoblastic according to GeneCards Suite gene sharing:

# Super pathways Score Top Affiliating Genes
1
Show member pathways
11.69 TIMP1 MYC
2
Show member pathways
11.47 TIMP1 MYC
3 11.01 TIMP1 MYC
4
Show member pathways
10.56 TIMP1 MYC

GO Terms for Lymphoma, Large-Cell, Immunoblastic

Biological processes related to Lymphoma, Large-Cell, Immunoblastic according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 positive regulation of cell proliferation GO:0008284 9.16 TIMP1 MYC
2 negative regulation of apoptotic process GO:0043066 8.96 TIMP1 MYC
3 cytokine-mediated signaling pathway GO:0019221 8.62 TIMP1 MYC

Sources for Lymphoma, Large-Cell, Immunoblastic

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
19 FMA
28 GO
29 GTR
30 HMDB
31 HPO
32 ICD10
33 ICD10 via Orphanet
34 ICD9CM
35 IUPHAR
36 KEGG
37 LifeMap
39 LOVD
41 MedGen
43 MeSH
44 MESH via Orphanet
45 MGI
48 NCI
49 NCIt
50 NDF-RT
53 NINDS
54 Novoseek
56 OMIM
57 OMIM via Orphanet
61 PubMed
63 QIAGEN
68 SNOMED-CT via HPO
69 TGDB
70 Tocris
71 UMLS
72 UMLS via Orphanet
Content
Loading form....